Acquisition of Kymriah (Tisagenlecleucel) Cell Therapy by CHU Ste-Justine
CHU Ste-Justine · Awarded contract
AwardedAcquisition of Kymriah (Tisagenlecleucel) Cell Therapy by CHU Ste-Justine
Awarded 10 Sep 2024
Awarded10 Sep 2024
Value$22,500,000.00
SupplierNOVARTIS PHARMA CANADA INC.
AgencyCHU Ste-Justine
ProvinceQuebec
CategoryHealth & Medical
About
CHU Ste-Justine awarded a contract to Novartis Pharma Canada Inc.
for the acquisition of Kymriah (tisagenlecleucel), a cell therapy, under the pharmaceutical products, medications, contraceptives, and vaccines category.
The contract, valued at CAD 22,500,000, was awarded through a non-competitive (negotiated) process.
Similar open tenders12
TenderCloses
Provincial Head, Complex Malignant Hematology — Ontario Health (Acute Leukemia, Stem Cell & CAR T Therapies)Health & Medical
03 Dec 2026
On-Demand Contract for Capital Works and Medical Equipment Installation — HEJ, HSFA, HSS & Santé Québec HQ (CHU de Québec – Université Laval)Construction
01 Dec 2026
Supply of Rezum Water Vapor Therapy System — Saskatchewan Health Authority (3-Year Contract Notice)Health & Medical
11 Dec 2026
Construction Management at Risk for UHN Princess Margaret Theranostics Centre – Imaging & Nuclear Therapy RedevelopmentConstruction
04 Dec 2026
HealthPRO RFP – Off‑Patent Hospital Injectable Pharmaceuticals (November 2026 Market Response)Health & Medical
15 Dec 2026
Parking Cleaning Services — CHU Sainte-Justine (Santé Québec)Health & Medical
26 Nov 2026
Supply of Off‑Patent, Non‑Hospital General Trade Pharmaceuticals – November 2026 Market ResponseHealth & Medical
15 Dec 2026
Supply of Lab Centrifuges & Cytofuges (Free‑Standing and Tabletop) – Contract from 1 Jan 2027Health & Medical
23 Nov 2026
Acquisition of Cell Sorter for Pharmaceutical Bioprocess DevelopmentResearch & Development
08 Dec 2026
Health Canada & PHAC Cybersecurity Informatics Services – National Capital Region (2‑Year Task-Based Contract)IT & Software
01 Dec 2026
Acquisition of Flow Cytometer for Pharmaceutical Bioprocess DevelopmentResearch & Development
08 Dec 2026
Oblitoxaximab Injection Procurement for Inhalation Anthrax – Public Health Agency of CanadaHealth & Medical
08 Dec 2026
GovMarket
We do the hard work.
You win the work.
We find the tenders, read the documents and track who wins, so your time goes on bids you can win.
–open health and medical tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then $59/CAD per month
Revenue from government work$312K won so far





